These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 2652505)

  • 1. Peri-operative antilymphoblast globulin (ALG) and delayed initiation of cyclosporine (CsA) diminishes the requirement for prolonged dialysis therapy after renal transplantation.
    Nestor ZJ; Rocher LL; Merion RM; Swartz RD; Turcotte JG; Campbell DA
    Transplant Proc; 1989 Feb; 21(1 Pt 2):1556-7. PubMed ID: 2652505
    [No Abstract]   [Full Text] [Related]  

  • 2. Sequential antilymphoblast globulin and cyclosporine for renal transplantation.
    Sommer BG; Henry ML; Ferguson RM
    Transplant Proc; 1987 Feb; 19(1 Pt 3):1879-80. PubMed ID: 3274445
    [No Abstract]   [Full Text] [Related]  

  • 3. Effect of discontinuing or restricting cyclosporine on late renal allograft rejection and function.
    Woodle ES; Heffron TG; Stuart JK; Thistlethwaite JR; Stuart FP
    Transplant Proc; 1989 Feb; 21(1 Pt 2):1641-2. PubMed ID: 2652536
    [No Abstract]   [Full Text] [Related]  

  • 4. Cyclosporin A (CsA) and azathioprine (Aza) overlap in renal allografts with impaired renal function.
    Castelao AM; Griñó JM; Sabaté I; Gilvernet S; Andres E; Sabater R; Alsina J
    Transplant Proc; 1989 Feb; 21(1 Pt 2):1540-1. PubMed ID: 2652497
    [No Abstract]   [Full Text] [Related]  

  • 5. Triple immunosuppressive therapy in immunologic high-risk renal allograft recipients.
    Cole E; Robinson C; Bear R
    Transplant Proc; 1989 Feb; 21(1 Pt 2):2026-7. PubMed ID: 2652662
    [No Abstract]   [Full Text] [Related]  

  • 6. Prolonged cyclosporine therapy to induce solid engraftment after renal transplantation.
    Weimar W; Versluis DJ; Wenting GJ; Derkx FH; Schalekamp MA; Jeekel J
    Transplant Proc; 1987 Feb; 19(1 Pt 3):1998-9. PubMed ID: 3274462
    [No Abstract]   [Full Text] [Related]  

  • 7. High long-term graft survival rates in kidney transplantation with the sequential association of antithymocyte globulin and cyclosporine A monotherapy.
    Hourmant M; Buzelin F; Dubigeon P; Soulillou JP
    Transplant Proc; 1987 Feb; 19(1 Pt 3):2113-4. PubMed ID: 3079073
    [No Abstract]   [Full Text] [Related]  

  • 8. A controlled trial comparing sequential antilymphocyte sera and cyclosporine therapy to conventional therapy in renal transplant recipients.
    Cardella CJ; Harding ME; deVeber GA; Honey J; Cook GT
    Transplant Proc; 1987 Feb; 19(1 Pt 3):1996-7. PubMed ID: 3079065
    [No Abstract]   [Full Text] [Related]  

  • 9. Effect of sequential Minnesota-antilymphocyte globulin and cyclosporine therapy in primary cadaveric renal transplant recipients with delayed graft function.
    Venkat KK; Kupin W; Oh HK
    Transplant Proc; 1989 Feb; 21(1 Pt 2):1544-5. PubMed ID: 2652499
    [No Abstract]   [Full Text] [Related]  

  • 10. Is sequential low-dose immunotherapy the preferred treatment in cadaveric renal transplantation?
    Posner MP; Mendez-Picon G; King A; Nelson KP; Spicer HG; Lee HM
    Transplant Proc; 1989 Feb; 21(1 Pt 2):1594-7. PubMed ID: 2652519
    [No Abstract]   [Full Text] [Related]  

  • 11. Intermodal immunosuppression for cadaver renal transplantation: results using antilymphocyte globulin, azathioprine, cyclosporine, and prednisone.
    Halloran P; Ludwin D; Bear R; Aprile M; McQuarrie B; Poole R; White N
    Transplant Proc; 1987 Feb; 19(1 Pt 3):1931-2. PubMed ID: 3274454
    [No Abstract]   [Full Text] [Related]  

  • 12. Pediatric renal transplantation results are improved with triple drug therapy with cyclosporine, azathioprine, and prednisone.
    MacDonell RC; Johnson K; Richie R; Nylander W; McMahon Y; Niblack G; Green W; Morrissey J; Ynares C
    Transplant Proc; 1989 Feb; 21(1 Pt 2):1701-4. PubMed ID: 2652557
    [No Abstract]   [Full Text] [Related]  

  • 13. Early function as the principal correlate of graft survival. A multivariate analysis of 200 cadaveric renal transplants treated with a protocol incorporating antilymphocyte globulin and cyclosporine.
    Halloran PF; Aprile MA; Farewell V; Ludwin D; Smith EK; Tsai SY; Bear RA; Cole EH; Fenton SS; Cattran DC
    Transplantation; 1988 Aug; 46(2):223-8. PubMed ID: 3043779
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Use of cyclosporine and Minnesota antilymphoblast globulin in the early postoperative treatment of primary cadaveric renal transplant recipients.
    Kupin W; Venkat KK; Oh HK; Dienst S; Levin NW
    Transplant Proc; 1987 Feb; 19(1 Pt 3):1882-5. PubMed ID: 3547893
    [No Abstract]   [Full Text] [Related]  

  • 15. Cyclosporin A as sole immunosuppressive agent for renal transplantation in children: effect on catch-up growth.
    Hodson EM; Knight JF; Sheil AG; Roy LP
    Transplant Proc; 1989 Feb; 21(1 Pt 2):1687-92. PubMed ID: 2652553
    [No Abstract]   [Full Text] [Related]  

  • 16. A randomized trial comparing cyclosporine with antilymphoblast-globulin-azathioprine for renal allograft recipients. Results at 2 1/2-6 years.
    Johnson CP; Simmons RL; Sutherland DE; Canafax DM; Ascher NL; Payne WD; Flick B; Najarian JS; Fryd DS
    Transplantation; 1988 Feb; 45(2):380-5. PubMed ID: 3278431
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cox regression analysis of outcome risk factors in 519 renal allograft recipients.
    Canafax DM; Savik SK; Draxler CA; Le CT; Ascher NL; Payne WD; Sutherland DE; Migliori RJ; Simmons RL; Najarian JS
    Transplant Proc; 1987 Feb; 19(1 Pt 3):1947-8. PubMed ID: 3274455
    [No Abstract]   [Full Text] [Related]  

  • 18. Sequential antilymphocyte globulin/cyclosporine immunosuppression in cadaveric renal transplantation. Effect of duration of ALG therapy.
    Stratta RJ; D'Alessandro AM; Armbrust MJ; Pirsch JD; Sollinger HW; Kalayoglu M; Belzer FO
    Transplantation; 1989 Jan; 47(1):96-102. PubMed ID: 2643236
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Low incidence of rejection and in vitro donor-specific hyporesponsiveness using pretransplant ALG, low-dose cyclosporine, and steroids in kidney cadaveric transplantation.
    Griñó JM; Bas J; Gonzalez C; Castelao AM; Seron D; Mestre M; Buendia E; Sabate R; Diaz C; Alsina J
    Transplant Proc; 1990 Aug; 22(4):1367-8. PubMed ID: 2143855
    [No Abstract]   [Full Text] [Related]  

  • 20. Individualization of immediate posttransplant immunosuppression. The value of antilymphocyte globulin in patients with delayed graft function.
    Matas AJ; Tellis VA; Quinn TA; Glicklich D; Soberman R; Veith FJ
    Transplantation; 1988 Feb; 45(2):406-9. PubMed ID: 3278434
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.